-
1
-
-
0036314025
-
Present and future treatment of pancreatic cancer
-
V Heinemann 2002 Present and future treatment of pancreatic cancer Semin Oncol 29 23 31 10.1053/sonc.2002.34269 1:CAS:528:DC%2BD38XlslKqtLk%3D 12094335 (Pubitemid 34753280)
-
(2002)
Seminars in Oncology
, vol.29
, Issue.3 SUPPL. 9
, pp. 23-31
-
-
Heinemann, V.1
-
2
-
-
22844448456
-
Molecular markers of early pancreatic cancer
-
DOI 10.1200/JCO.2005.19.711
-
M Goggins 2005 Molecular markers of early pancreatic cancer J Clin Oncol 23 4524 4531 10.1200/JCO.2005.19.711 1:CAS:528:DC%2BD2MXnsl2ksL4%3D 16002843 (Pubitemid 46196582)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.20
, pp. 4524-4531
-
-
Goggins, M.1
-
3
-
-
22844436349
-
Adjuvant treatment for resectable pancreatic cancer
-
DOI 10.1200/JCO.2005.17.954
-
YJ Chua D Cunningham 2005 Adjuvant treatment for resectable pancreatic cancer J Clin Oncol 23 4532 4537 10.1200/JCO.2005.17.954 1:CAS:528: DC%2BD2MXnsl2ksL8%3D 16002844 (Pubitemid 46196583)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.20
, pp. 4532-4537
-
-
Chua, Y.J.1
Cunningham, D.2
-
4
-
-
0036995485
-
Gemcitabine in the treatment of advanced pancreatic cancer a comparison analysis of randomized trials
-
1:CAS:528:DC%2BD3sXhslehtL8%3D 12577228
-
V Heinemann 2002 Gemcitabine in the treatment of advanced pancreatic cancer a comparison analysis of randomized trials Semin Oncol 29 9 16 1:CAS:528:DC%2BD3sXhslehtL8%3D 12577228
-
(2002)
Semin Oncol
, vol.29
, pp. 9-16
-
-
Heinemann, V.1
-
5
-
-
18844431062
-
Pancreatic cancer: Basic and clinical aspects
-
DOI 10.1053/j.gastro.2005.04.001, PII S0016508505006323
-
G Schneider JT Siveke F Eckel RM Schmid 2005 Pancreatic cancer; basic and clinical aspects Gastroenterology 128 1606 1625 10.1053/j.gastro.2005.04.001 1:CAS:528:DC%2BD2MXltlOgtbw%3D 15887154 (Pubitemid 40692555)
-
(2005)
Gastroenterology
, vol.128
, Issue.6
, pp. 1606-1625
-
-
Schneider, G.1
Siveke, J.T.2
Eckel, F.3
Schmid, R.M.4
-
6
-
-
0036994860
-
Past and present treatment of pancreatic adenocarcinoma: Chemotherapy as a standard treatment modality
-
1:CAS:528:DC%2BD3sXhslehtL4%3D 12577227
-
JL Abbruzzese 2002 Past and present treatment of pancreatic adenocarcinoma: chemotherapy as a standard treatment modality Semin Oncol 29 2 8 1:CAS:528:DC%2BD3sXhslehtL4%3D 12577227
-
(2002)
Semin Oncol
, vol.29
, pp. 2-8
-
-
Abbruzzese, J.L.1
-
8
-
-
18844375044
-
Treatment for pancreatic cancer: Current therapy and continued progress
-
DOI 10.1053/j.gastro.2005.03.039, PII S0016508505004658
-
AC Lockhart ML Rothenberg JD Berlin 2005 Treatment for pancreatic cancer; current therapy and continued progress Gastroenterology 128 1642 1654 10.1053/j.gastro.2005.03.039 1:CAS:528:DC%2BD2MXltlOgtb0%3D 15887156 (Pubitemid 40692557)
-
(2005)
Gastroenterology
, vol.128
, Issue.6
, pp. 1642-1654
-
-
Lockhart, A.C.1
Rothenberg, M.L.2
Berlin, J.D.3
-
9
-
-
0014691062
-
Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer
-
10.1016/S0140-6736(69)92326-5 1:STN:280:DyaE3c%2FgsFyjsQ%3D%3D 4186452
-
CG Moertel DS Childs Jr RJ Reitemeier MY Colby Jr MA Holbrook 1969 Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer Lancet 2 865 867 10.1016/S0140-6736(69) 92326-5 1:STN:280:DyaE3c%2FgsFyjsQ%3D%3D 4186452
-
(1969)
Lancet
, vol.2
, pp. 865-867
-
-
Moertel, C.G.1
Childs Jr, D.S.2
Reitemeier, R.J.3
Colby Jr, M.Y.4
Holbrook, M.A.5
-
10
-
-
0019410935
-
Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group
-
DOI 10.1002/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0. CO;2-4
-
CG Moertel S Frytak RG Hahn MJ O'Connell RJ Reitemeier J Rubin, et al. 1981 Therapy of locally unresectable pancreatic carcinoma a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil Cancer 48 1705 1710 10.1002/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0. CO;2-4 1:STN:280:DyaL38%2FisFaqtg%3D%3D 7284971 (Pubitemid 11022870)
-
(1981)
Cancer
, vol.48
, Issue.8
, pp. 1705-1710
-
-
Moertel, C.G.1
Frytak, S.2
Hahn, R.G.3
-
11
-
-
0023722682
-
Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone
-
Gastrointestinal Tumor Study Group. 10.1093/jnci/80.10.751
-
Gastrointestinal Tumor Study Group 1988 Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone J Natl Cancer Inst 80 751 755 10.1093/jnci/80.10.751
-
(1988)
J Natl Cancer Inst
, vol.80
, pp. 751-755
-
-
-
12
-
-
0021918519
-
Treatment of locally unresectable caner of the stomach and pancreas: A randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil-an Eastern Cooperative Oncology Group study
-
1:STN:280:DyaL2M7jtlOktA%3D%3D 3973648
-
DJ Klaassen JM MacIntyre GE Catton PF Engstrom CG Moertel 1985 Treatment of locally unresectable caner of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil-an Eastern Cooperative Oncology Group study J Clin Oncol 3 373 378 1:STN:280:DyaL2M7jtlOktA%3D%3D 3973648
-
(1985)
J Clin Oncol
, vol.3
, pp. 373-378
-
-
Klaassen, D.J.1
MacIntyre, J.M.2
Catton, G.E.3
Engstrom, P.F.4
Moertel, C.G.5
-
13
-
-
8244254377
-
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
-
1:CAS:528:DyaK2sXlsFKksLY%3D 9196156
-
HA Burris 3rd MJ Moore J Andersen MR Green ML Rothenberg MR Modiano, et al. 1997 Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 15 2403 2413 1:CAS:528:DyaK2sXlsFKksLY%3D 9196156
-
(1997)
J Clin Oncol
, vol.15
, pp. 2403-2413
-
-
Burris III, H.A.1
Moore, M.J.2
Andersen, J.3
Green, M.R.4
Rothenberg, M.L.5
Modiano, M.R.6
-
14
-
-
50849115450
-
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study
-
Chauffert B, Mornex F, Bonnetain F, Rougier P, Mariette C, Bouché O, et al. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. Ann Oncol. 2008;19:1592-9.
-
(2008)
Ann Oncol.
, vol.19
, pp. 1592-1599
-
-
Chauffert B, M.1
-
15
-
-
0003412927
-
-
Sobin LH, Wittekind C, editors 6th ed. New York: Wiley-Liss
-
Sobin LH, Wittekind C, editors. UICC-TNM classification of malignant tumours, 6th ed. New York: Wiley-Liss; 2002.
-
(2002)
UICC-TNM Classification of Malignant Tumours
-
-
-
16
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors European organization for research and treatment of cancer, national cancer institute of the United States, national cancer institute of Canada
-
10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10655437
-
P Therasse SG Arbuck EA Eisenhauer J Wanders RS Kaplan L Rubinstein, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10655437
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
Wanders, J.4
Kaplan, R.S.5
Rubinstein, L.6
-
18
-
-
43449093718
-
Chemoradiotherapy for unresectable pancreatic cancer
-
DOI 10.1007/s10147-007-0763-x
-
E Ben-Josef TS Lawrence 2008 Chemoradiotherapy for unresectable pancreatic cancer Int J Clin Oncol 13 121 126 10.1007/s10147-007-0763-x 18463955 (Pubitemid 351668178)
-
(2008)
International Journal of Clinical Oncology
, vol.13
, Issue.2
, pp. 121-126
-
-
Ben-Josef, E.1
Lawrence, T.S.2
-
19
-
-
4344626528
-
Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer
-
1:CAS:528:DC%2BD2cXmsVCgsLk%3D 15226765
-
T Okusaka Y Ito H Ueno M Ikeda Y Takezako C Morizane, et al. 2004 Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer Br J Cancer 91 673 677 1:CAS:528:DC%2BD2cXmsVCgsLk%3D 15226765
-
(2004)
Br J Cancer
, vol.91
, pp. 673-677
-
-
Okusaka, T.1
Ito, Y.2
Ueno, H.3
Ikeda, M.4
Takezako, Y.5
Morizane, C.6
|